Literature DB >> 25015859

Acute myeloid leukemia with monosomal karyotype: morphologic, immunophenotypic, and molecular findings.

Olga K Weinberg1, Robert S Ohgami2, Lisa Ma2, Katie Seo2, Li Ren2, Jason R Gotlib2, Mahesh Seetharam3, Athena Cherry2, Daniel A Arber2.   

Abstract

OBJECTIVES: Acute myeloid leukemia (AML) with monosomal karyotype (MK) recently has been reported to be associated with worse outcome than the traditional complex karyotype.
METHODS: In this retrospective study of 111 patients with AML, we identified 14 patients with MK (13% of all patients with AML) using the definition proposed by Breems et al.
RESULTS: Five (36%) of these 14 patients had a loss of a single chromosome in the presence of other structural abnormalities, and nine (64%) had a loss of two or more autosomal chromosomes. Patients with AML-MK presented at an older age, with lower bone marrow blasts, and their blasts less frequently expressed CD34. Most patients with AML-MK had morphologic multilineage dysplasia and were predominantly subclassified as having AML with myelodysplasia-related changes (AML-MRC). Molecular analysis showed a significant absence of NPM1 and FLT3 in patients with AML-MK.
CONCLUSIONS: Outcome data showed that patients with AML-MK had significantly worse overall survival, disease-free survival, and complete response compared with the rest of the patients with AML as well as within the AML-MRC group. Copyright© by the American Society for Clinical Pathology.

Entities:  

Keywords:  Acute myeloid leukemia; Monosomal karyotype; Myelodysplasia

Mesh:

Year:  2014        PMID: 25015859     DOI: 10.1309/AJCPMLO84JDNVLNK

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  8 in total

Review 1.  Prognostic Significance of Complex Karyotypes in Acute Myeloid Leukemia.

Authors:  Yahya Daneshbod; Leila Kohan; Vahideh Taghadosi; Olga K Weinberg; Daniel A Arber
Journal:  Curr Treat Options Oncol       Date:  2019-02-11

2.  Immunotherapy for acute myeloid leukemia: from allogeneic stem cell transplant to novel therapeutics.

Authors:  David A Knorr; Aaron D Goldberg; Eytan M Stein; Martin S Tallman
Journal:  Leuk Lymphoma       Date:  2019-07-23

3.  Next-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutations.

Authors:  Robert S Ohgami; Lisa Ma; Jason D Merker; Jason R Gotlib; Iris Schrijver; James L Zehnder; Daniel A Arber
Journal:  Mod Pathol       Date:  2014-11-21       Impact factor: 7.842

Review 4.  The International Consensus Classification of acute myeloid leukemia.

Authors:  Olga K Weinberg; Anna Porwit; Attilio Orazi; Robert P Hasserjian; Kathryn Foucar; Eric J Duncavage; Daniel A Arber
Journal:  Virchows Arch       Date:  2022-10-20       Impact factor: 4.535

Review 5.  The complex karyotype in hematological malignancies: a comprehensive overview by the Francophone Group of Hematological Cytogenetics (GFCH).

Authors:  F Nguyen-Khac; A Bidet; A Daudignon; M Lafage-Pochitaloff; G Ameye; C Bilhou-Nabéra; E Chapiro; M A Collonge-Rame; W Cuccuini; N Douet-Guilbert; V Eclache; I Luquet; L Michaux; N Nadal; D Penther; B Quilichini; C Terre; C Lefebvre; M-B Troadec; L Véronèse
Journal:  Leukemia       Date:  2022-04-16       Impact factor: 12.883

6.  Genotype-outcome correlations in pediatric AML: the impact of a monosomal karyotype in trial AML-BFM 2004.

Authors:  M Rasche; C von Neuhoff; M Dworzak; J-P Bourquin; J Bradtke; G Göhring; G Escherich; G Fleischhack; N Graf; B Gruhn; O A Haas; T Klingebiel; B Kremens; T Lehrnbecher; A von Stackelberg; J Tchinda; Z Zemanova; C Thiede; N von Neuhoff; M Zimmermann; U Creutzig; D Reinhardt
Journal:  Leukemia       Date:  2017-04-25       Impact factor: 11.528

Review 7.  Monosomal karyotype in myeloid neoplasias: a literature review.

Authors:  Luisa Anelli; Crescenza Pasciolla; Antonella Zagaria; Giorgina Specchia; Francesco Albano
Journal:  Onco Targets Ther       Date:  2017-04-20       Impact factor: 4.147

8.  TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML.

Authors:  Olga K Weinberg; Alexa Siddon; Yazan F Madanat; Jeffrey Gagan; Daniel A Arber; Paola Dal Cin; Damodaran Narayanan; Madhu M Ouseph; Jason H Kurzer; Robert P Hasserjian
Journal:  Blood Adv       Date:  2022-05-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.